INFLIXIMAB

139760 reported adverse events

Drug classes: Tumor Necrosis Factor Blocker [EPC]

These side effects are most commonly reported by patients taking INFLIXIMAB:

# Side effect Count
0 DRUG INEFFECTIVE 22891
1 OFF LABEL USE 12036
2 INFUSION RELATED REACTION 10325
3 RHEUMATOID ARTHRITIS 8791
4 PAIN 6917
5 PRODUCT USE ISSUE 6908
6 ARTHRALGIA 6727
7 NAUSEA 5962
8 FATIGUE 5293
9 CONDITION AGGRAVATED 5239
See all common reactions for INFLIXIMAB

INFLIXIMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 265 0.9233
1 RED BLOOD CELL SEDIMENTATION RATE 82 0.7593
2 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 605 0.6938
3 SWOLLEN JOINT COUNT INCREASED 65 0.5752
4 GRANULOMA SKIN 244 0.5648
5 PEMPHIGUS 1560 0.5591
6 MUSCULOSKELETAL DEFORMITY 87 0.5241
7 HEPATOSPLENIC T-CELL LYMPHOMA 160 0.5096
8 RHEUMATOID FACTOR NEGATIVE 73 0.5069
9 CONTRAINDICATION TO VACCINATION 77 0.4904
See all enriched reactions for INFLIXIMAB